The big story of 2020 isn’t hard to judge – it’s the pandemic. If we’re lucky, it won’t also be the big story of 2021. But it’s going to fight for that spot. It’s certainly not going to wane in the face of the other big stories – riots, the election, the recession, the trade war, trillions in stimulus, etc. The virus is at the top of the charts, and for good reason: 210k dead just in the US in a matter of months. Can Allstar Health Brand Inc ALST be part of the bigger solution?
Now, with President Trump in the hospital with the virus himself, the intensity of this theme in the news and public zeitgeist is likely to ratchet up even further. As a result, companies that provide viable support and resources in the battle to defeat it and reclaim our cultural sense of normalcy will likely come to the fore once again as well.
With that in mind, we take a close look today at AllStar Health Brands Inc (OTCMKTS:ALST), a specialty pharmaceutical and nutritional supplements company focusing recently on personal protection equipment and the development of a mobile virus testing lab in partnership with TPT Global Tech, a technology and solutions company.
Testing, Testing, Testing!
The importance of testing in the process of controlling and battling the pandemic cannot be overstated. If you are trying to see something invisible, you need a system. Bats use sonar. They fly around blind, and send out high-pitched chirps, and specialize in detecting the rebounding sound waves, which paint a picture of the 3d topography of their surroundings. The more chirps, the more granular and precise their sense of their surroundings becomes.
Similarly, the more tests we do, the more precisely we will understand where the virus is. If we understand where it is (ie, who has it, and who might), then we can reduce cases, hospitalizations, and deaths, all while reopening our economy more robustly and maintaining our jobs and livelihoods.
Put another way, in the absence of a widely trusted, widely available, safe, and highly effective vaccine, testing is our most important weapon. And AllStar Health Brands Inc (OTCMKTS:ALST) is a primary play in that narrative.
The concept of a mobile testing lab is a major innovation. One of the core assets at this point for AllStar Health Brands Inc (OTCMKTS:ALST) is its partnership with TPT Global Tech, a technology and solutions company. The two companies are collaborating to create and distribute the QuickLAB module, a rapid testing solution for Covid-19.
As noted above, testing is going to be a huge facet of any solution that can head off the disaster that might otherwise await us this winter as cold and flu season picks up and viruses have an easier time spreading in the northern hemisphere.
The two companies had already recently signed an agreement for Mexico and other Latin American countries through TPT Global Tech’s partner New Orbit Technologies. Now, as of last month, they have signed an expanded agreement to bring QuickLAB distribution to Canada and US to add to the existing Non-Exclusive Distribution Agreement for Mexico and other Latin American countries.
“We are very pleased to announce the expansion of our initial non-exclusive partnership agreement to now include Canada and the US. AllStar Health Brands’ goal is to work with TPT Medtech for both the geographic expansion of the QuikLAB modules within the US and Canada and also offer the best testing technologies within the QuikLAB modules. Both companies have a shared vision to make one-stop, mass testing for Covid-19, a near-term reality in the Americas,” stated Dr. Daniel Bagi, President of AllStar.
According to the release, AllStar believes that given the high Covid-19 infection rates around the world, and the ability to set up the QuikLAB testing modules at almost any location, the QuikLAB option may be part of the solution in combating the effects of this pandemic.
The company notes that the QuikLAB testing modules offer a fast, complete testing option, at a rapid throughput, – up to 50 tests/hour, using either the PCR or antibody tests or both currently available on the market. The goal is to provide results within minutes to a few short hours, so appropriate treatment or isolation protocols can be recommended based on the results of the testing.
And More Testing!
Co-Diagnostics, Inc. (Nasdaq:CODX) develops, manufactures and markets a state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.
According to ALST’s release, the PCR Machine order is part of a sales program to include CO-Diagnostics’ proprietary LOGIX Smart TM Coronavirus Disease 2019 (COVID 19) kits.
Mr. Bagi (again, President of AllStar) stated, “As the COVID-19 infection rate now seems to have increased again, we believe the need for testing will continue to increase in parallel. Allstar is very pleased to be offering the CO-Diagnostics testing system in the US, as we believe it has certain advantages over other PCR test systems, such as a proprietary blend of co-primers, which may increase the accuracy of the test results, possibly resulting in less false positives. After analyzing some of our client needs, we determined the CODX system fits perfectly into a more decentralized testing program and can give results in a matter of a couple of hours.”